GSK Flovent/Advair Diskus Needs More COPD Data; Serevent Cleared For COPD

FDA is seeking additional efficacy data on GlaxoSmithKline's Flovent Diskus and Advair Diskus for chronic obstructive pulmonary disease before approving the products for the supplementary indication